Skip to content
MarketScale
‹ Back to IndustriesHealthcare

World Water Day

World Water Day began in 1993 and has occurred on March 22nd every year since. This celebration of water seeks to raise awareness for the 2.2 billion people on the planet who live without access to safe water. Joshua Jensen, Senior Sales Director, Western Hemisphere for Trillium Flow Technologies, spoke to Michelle Dawn Moody about…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

World Water Day began in 1993 and has occurred on March 22nd every year since. This celebration of water seeks to raise awareness for the 2.2 billion people on the planet who live without access to safe water. Joshua Jensen, Senior Sales Director, Western Hemisphere for Trillium Flow Technologies, spoke to Michelle Dawn Moody about some of the initiatives Trillium’s involved with to make this mission a reality.

Trillium’s mission to provide safe drinking water solutions for millions in North America dates back eighty-five years. While Jensen humbly suggested Trillium Flow’s products play only a small part in these efforts, they contribute to bringing safe water to over 300 million people in North America. “We work with and support some of the largest water and wastewater districts across North America, helping them develop solutions for their water or wastewater treatment facilities,” Jensen said.

Trillium offers critical water pumping-based products manufactured in their U.S. facility located in Fresno, California. Their Floway brand provides vertical turbine pumps for water, wastewater, and dewatering applications. “Our Floway products are NSF 61 and 372-certified for drinking water and drinking water treatment chemicals,” Jensen said. “Which allows us to support the demanding services of the water market.” Both Floway and Trillium’s Wemco line are industry-leading, known for their quality and longevity in the water market.

While the United States may have access and infrastructure to support clean and safe drinking water, many areas across the globe do not, which is why Jensen said Trillium’s support of World Water Day is crucial. Climate change brings new challenges into the equation. “In just North America alone, the Western United States is experiencing some of the worst drought periods in the last 100 years and record growth, putting a greater strain on our water supplies.” Water consumption reduction, reuse, and recycled water technologies will be needed to maximize available water supplies.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512